Neoprobe Corporation (OTC BB: NEOP) announces the employment agreement with Frederick O. Cope, Ph.D.
On 24.02.2010, in its 8k sec filing form, Item 5.02, related to change of directors, the Neoprobe Corporation (OTC BB: NEOP) announced an employment agreement with Frederick O. Cope, Ph.D., the Company’s Vice President, Pharmaceutical Research and Clinical Development. The new agreement came in to force on 15.02.2010 and will be terminated on 31.12.2010.
We couldn’t [...]